within Pharmacolibrary.Drugs.ATC.C;

model C04AX20
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 50 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 300 / 1000000,
    adminCount     = 1,
    Vd             = 0.2,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0003333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Buflomedil is a vasoactive drug, formerly used for the treatment of peripheral arterial disease and related circulatory disorders. Due to concerns regarding serious adverse effects such as neurotoxicity and cardiotoxicity, the drug has been withdrawn from the market in many countries and is not approved for clinical use today.</p><h4>Pharmacokinetics</h4><p>Estimated typical pharmacokinetic parameters for an adult population; no relevant publication with detailed PK found.</p><h4>References</h4><ol><li><p>Gundert-Remy, U, et al., &amp; Aynilian, GH (1981). The clinical pharmacokinetics of buflomedil in normal subjects after intravenous and oral administration. <i>European journal of clinical pharmacology</i> 20(6) 459–463. DOI:<a href=&quot;https://doi.org/10.1007/BF00542100&quot;>10.1007/BF00542100</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7286057/&quot;>https://pubmed.ncbi.nlm.nih.gov/7286057</a></p></li><li><p>Rey, E, et al., &amp; Olive, G (1980). Pharmacokinetics of buflomedil after intravenous and oral administration. <i>International journal of clinical pharmacology, therapy, and toxicology</i> 18(10) 437–441. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7203720/&quot;>https://pubmed.ncbi.nlm.nih.gov/7203720</a></p></li><li><p>de Bernardi di Valserra, M, et al., &amp; Borgonovo, E (1992). Pharmacokinetics of a sustained release formulation of pyridoxal phosphate of buflomedil after single or repeated oral doses in healthy volunteers. <i>Arzneimittel-Forschung</i> 42(5) 632–636. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1530676/&quot;>https://pubmed.ncbi.nlm.nih.gov/1530676</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C04AX20;
